Loading…
Loading…
Healthcare is one of the most defensive and complex sectors for individual investors. Large-cap pharma giants like Johnson & Johnson and AbbVie offer dividend income with moderate risk. Biotech names like Moderna carry extreme binary risk — a single trial result can move the stock 30–60% overnight. Understanding each sub-sector's distinct risk profile is essential before investing.
Johnson & Johnson
Healthcare conglomerate; Dividend Aristocrat, very low risk
Eli Lilly
GLP-1 weight-loss drug leader; high-momentum growth pharma
AbbVie
Immunology blockbuster Humira; high dividend yield
UnitedHealth Group
Largest US health insurer; defensive mega-cap
Pfizer
COVID-vaccine maker; post-pandemic revenue normalisation
Moderna
mRNA vaccine pioneer; high-risk speculative biotech profile
AstraZeneca
UK/Sweden pharma; oncology focus, strong pipeline
Novartis
Swiss pharma giant; diversified drug portfolio
Roche
Swiss diagnostics + pharma; defensive quality
Sanofi
French pharma; consumer health + rare diseases
Bayer
German pharma + agriculture; under legal pressure from Roundup
Healthcare stocks are analysed using multiple quantitative signals: volatility (30-day vs 365-day), market beta, maximum drawdown history, news sentiment, and valuation risk. GlobalTrack combines these into a 0–100 risk score. Click any ticker above to see the full breakdown in plain language — no finance degree required.
Healthcare is one of the most defensive and complex sectors for individual investors. Large-cap pharma giants like Johnson & Johnson and AbbVie offer dividend income with moderate risk. Biotech names like Moderna carry extreme binary risk — a single trial result can move the stock 30–60% overnight. …